NCT02350348

Brief Summary

To study the 30-day morbidity and mortality after neonatal anaesthesia, and predictive factors that can be responsible for poor outcome.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2016

Typical duration for all trials

Geographic Reach
9 countries

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 29, 2015

Completed
1.1 years until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

February 15, 2022

Status Verified

July 1, 2020

Enrollment Period

1 year

First QC Date

January 15, 2015

Last Update Submit

January 31, 2022

Conditions

Keywords

neonatesinfantsanaesthesiamortalityadverse effectsEpidemiological StudyEuropean Society of Anaesthesiology

Outcome Measures

Primary Outcomes (1)

  • The incidence of interventions performed by the anaesthesia team in response to (i) a critical event or (ii) a major change of physiological parameters during anaesthesia management.

    This is a composite that will include several physiological parameters to be observed: (1) airway management, (2) oxygenation, (3) alveolar ventilation, (4) glycaemia and Na+, (5) cardiovascular instability, (6) body temperature, (7) brain oxygenation, and (8) anaemia.

    Anaesthesia time : up to 120 minutes post-anaesthesia either in Post Anesthesia Care Unit (PACU) or neonatal ward

Secondary Outcomes (5)

  • The incidence of adverse events

    120 minutes post-anaesthesia either in Post Anesthesia Care Unit (PACU) or neonatal ward

  • Mortality

    up to 30 days after anaesthesia

  • Morbidity

    at 30 days after anaesthesia

  • In- and out-hospital mortality

    90 days after anaesthesia

  • In- and out-hospital morbidity

    90 days after anaesthesia

Eligibility Criteria

AgeUp to 60 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates and infants from birth to 60 weeks of post-menstrual age

You may qualify if:

  • children from birth to 60 weeks of post-menstrual age undergoing anaesthesia for surgical or diagnostic procedures admitted to participating centres during a predetermined 12-week recruitment period
  • all elective inpatient or outpatient surgical procedures performed under general anaesthesia with or without regional analgesia, or under regional anaesthesia alone;
  • all diagnostic procedures performed under general anaesthesia;
  • all urgent or emergency procedures performed in- or out-of-hours.
  • all procedures performed in Neonatal Intensive Care Unit (NICU) / Paediatric Intensive Care Unit (PICU) or directly admitted from intensive care to the operating room

You may not qualify if:

  • \- Infants aged over 60 weeks of age on the day of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Cliniques Universitaires St Luc

Brussels, 1200, Belgium

Location

Odense University Hospital

Odense, Denmark

Location

Cnopf'sche Kinderklinik/Klinik Hallerwiese

Nuremberg, 90419, Germany

Location

Instituto Giannina Gaslini

Genoa, 6100, Italy

Location

Wilhelmina Childrens Hospital

Utrecht, Netherlands

Location

Clinical University Hospital Department of Anaesthesiology and Intensive Care

Wroclaw, 50-556, Poland

Location

University Childrens hospital

Belgrade, 11000, Serbia

Location

Geneva University Hospitals

Geneva, Switzerland

Location

Royal Aberdeen Children's Hospital

Aberdeen, AB25 2ZN, United Kingdom

Location

Great Ormond St Hospital for Children's NHS

London, WC1N 1EH, United Kingdom

Location

Related Publications (7)

  • Disma N, Leva B, Dowell J, Veyckemans F, Habre W. Assessing anaesthesia practice in the vulnerable age group: NECTARINE: A European prospective multicentre observational study. Eur J Anaesthesiol. 2016 Apr;33(4):233-5. doi: 10.1097/EJA.0000000000000414. No abstract available.

    PMID: 26928166BACKGROUND
  • Neumann C, Schenk A, Schindler E, Becke-Jakob K; German Nectarine Group Collaborators. Epidemiology, Morbidity and Mortality Associated With Anesthesia in Early Life: A Subgroup Analysis of the German NEonate and Children audiT of Anesthesia pRactice IN Europe (NECTARINE) Cohort. Paediatr Anaesth. 2026 Jan 16. doi: 10.1002/pan.70115. Online ahead of print.

  • Fuchs A, Disma N, Engelhardt T, Marchesini V, Riedel T, Boda K, Habre W, Riva T; NECTARINE Steering Committee; NECTARINE Group of the European Society of Anaesthesiology and Intensive Care Clinical Trial Network. Ventilation strategies and risk factors for intraoperative respiratory critical events and postoperative pulmonary complications in neonates and small infants: a secondary analysis of the NECTARINE cohort☆. Br J Anaesth. 2025 Nov;135(5):1528-1536. doi: 10.1016/j.bja.2024.12.038. Epub 2025 Feb 20.

  • Disma N, Engelhardt T, Hansen TG, de Graaff JC, Virag K, Habre W; NECTARINE Group of the European Society of Anaesthesiology and Intensive; AUSTRIA (Maria Vittinghoff); BELGIUM (Francis Veyckemans); CROATIA (Sandra Kralik); CZECH REPUBLIC (Jiri Zurek); DENMARK (Tom Hansen); ESTONIA (Reet Kikas); FINLAND (Tuula Manner); FRANCE (Christophe Dadure, Anne Lafargue); GERMANY (Karin Becke, Claudia Hoehne); GREECE (Anna Malisiova); HUNGARY (Andrea Szekely); IRELAND (Brendan O'Hare); ITALY (Nicola Disma); LATVIA (Zane Straume); LITHUANIA (Laura Lukosiene); LUXEMBOURG (Bernd Schmitz); MALTA (Francis Borg); NETHERLANDS (Jurgen de Graaff); NORWAY (Wenche B Boerke); POLAND (Marzena Zielinska); PORTUGAL (Maria Domingas Patuleia); ROMANIA (Radu Tabacaru); SERBIA (Dusica Simic); SLOVAKIA (Miloslav Hanula); SLOVENIA (Jelena Berger); SPAIN (Ignacio Galvez Escalera); SWEDEN (Albert Castellheim); SWITZERLAND (Walid Habre); TURKEY (Dilek Ozcengiz - Zehra Hatipoglu); UKRAINE (Dmytro Dmytriiev); UNITED KINGDOM (Thomas Engelhardt, Suellen Walker); Management Team. Neonates undergoing pyloric stenosis repair are at increased risk of difficult airway management: secondary analysis of the NEonate and Children audiT of Anaesthesia pRactice IN Europe. Br J Anaesth. 2022 Nov;129(5):734-739. doi: 10.1016/j.bja.2022.07.041. Epub 2022 Sep 6.

  • Fuchs A, Disma N, Virag K, Ulmer F, Habre W, de Graaff JC, Riva T; NECTARINE Group of the European Society of Anaesthesiology and Intensive Care Clinical Trial Network. Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study. Eur J Anaesthesiol. 2022 Mar 1;39(3):252-260. doi: 10.1097/EJA.0000000000001646.

  • Disma N, Veyckemans F, Virag K, Hansen TG, Becke K, Harlet P, Vutskits L, Walker SM, de Graaff JC, Zielinska M, Simic D, Engelhardt T, Habre W; NECTARINE Group of the European Society of Anaesthesiology Clinical Trial Network; Austria; Belgium; Croatia; Czech Republic; Denmark; Estonia; Finland; France; Germany; Greece; Hungary; Ireland; Italy; Latvia; Lithuania; Luxembourg; Malta; Netherlands; Norway; Poland; Portugal; Romania; Serbia; Slovakia; Slovenia; Spain; Switzerland; Turkey; Ukraine; United Kingdom. Morbidity and mortality after anaesthesia in early life: results of the European prospective multicentre observational study, neonate and children audit of anaesthesia practice in Europe (NECTARINE). Br J Anaesth. 2021 Jun;126(6):1157-1172. doi: 10.1016/j.bja.2021.02.016. Epub 2021 Apr 1.

  • Disma N, Virag K, Riva T, Kaufmann J, Engelhardt T, Habre W; NECTARINE Group of the European Society of Anaesthesiology Clinical Trial Network; AUSTRIA (Maria Vittinghoff); BELGIUM (Francis Veyckemans); CROATIA (Sandra Kralik); CZECH REPUBLIC (Jiri Zurek); DENMARK (Tom Hansen); ESTONIA (Reet Kikas); FINLAND (Tuula Manner); FRANCE (Christophe Dadure, Anne Lafargue); GERMANY (Karin Becke, Claudia Hoehne); GREECE (Anna Malisiova); HUNGARY (Andrea Szekely); IRELAND (Brendan O'Hare); ITALY (Nicola Disma); LATVIA (Zane Straume); LITHUANIA (Laura Lukosiene); LUXEMBOURG (Bernd Schmitz); MALTA (Francis Borg); NETHERLANDS (Jurgen de Graaff); NORWAY (Wenche B Boerke); POLAND (Marzena Zielinska); PORTUGAL (Maria Domingas Patuleia); ROMANIA (Radu Tabacaru); SERBIA (Dusica Simic); SLOVAKIA (Miloslav Hanula); SLOVENIA (Jelena Berger); SPAIN (Ignacio Galvez Escalera); SWEDEN (Albert Castellheim); SWITZERLAND (Walid Habre); TURKEY (Dilek Ozcengiz - Zehra Hatipoglu); UKRAINE (Dmytro Dmytriiev); UNITED KINGDOM (Thomas Engelhardt, Suellen Walker); Management Team. Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE): a prospective European multicentre observational study. Br J Anaesth. 2021 Jun;126(6):1173-1181. doi: 10.1016/j.bja.2021.02.021. Epub 2021 Apr 1.

Study Officials

  • Nicola Disma, MD

    Dept. Anesthesia - Istituto G. Gaslini - Genoa - Italy

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2015

First Posted

January 29, 2015

Study Start

March 1, 2016

Primary Completion

March 1, 2017

Study Completion

June 1, 2019

Last Updated

February 15, 2022

Record last verified: 2020-07

Locations